Outcome in Advanced Ovarian Cancer following an Appropriate and Comprehensive Effort at Upfront Cytoreduction: A Twenty-Year Experience in a Single Cancer Institute

Table 4

Comparison with other studies.

Author, year	𝑛	% stage IV	Optimal surgery		5-year survival
			Residual disease	%	Residual disease	%
Eisenkop et al., 1998 [13]	163	17%	0 cm	98.8%	0	52%
					>0	29%
Scarabelli et al., 2000 [14]	66	11%	<2 cm	100%	0	42.2%
					>0-1	21.3%
Chi et al., 2001 [15]	282	23%	<1 cm	26%	0-1	50%
					>1-2	28%
					>2	21%
Eisenkop, et al., 2003 [16]	408	0%	<1 cm	96%	0-1	52%
					>1-2	30%
					>2	0%
Present study	340	22.75%	<1 cm	40%	0	55.4%
					>0-1	43.5%
					>1	24.2%